Trends - AstraZeneca - Business Recorder

AstraZeneca

Indonesia pledges free COVID-19 vaccines, with president first in line

The president, widely known as Jokowi, said he had instructed the finance minister to reallocate spending for the programme.

Published 16 Dec, 2020 04:55pm

Business & Finance

Fosun Pharma to buy 100mn doses of BioNTech's COVID-19 vaccine for mainland China

Separately, Shenzhen Kangtai Biological Products Co Ltd aims to have enough capacity to produce at least 100 million doses of a vaccine candidate from British partner AstraZeneca PLC by year-end.

Published 16 Dec, 2020 10:04am

World

Jordan approves Pfizer-BioNTech Covid vaccine

Jordan's green light for the Pfizer vaccine follows those of Bahrain and Saudi Arabia and came six days after Britain launched the world's first mass innoculation campaign using the vaccine.

Published 15 Dec, 2020 02:52pm

World

Argentina exceeds 1.5 million coronavirus cases: Health Ministry

However, medics insist that precautionary isolation measures and robust virus tracking will be needed for the near future.

Published 15 Dec, 2020 09:43am

Markets

Wall St opens higher as travel stocks rally on vaccine roll-out

The S&P 500 opened higher by 11.81 points, or 0.32pc, at 3,675.27, while the Nasdaq Composite gained 69.57 points, or 0.56pc, to 12,447.44 at the opening bell.

Published 14 Dec, 2020 07:47pm

World

AstraZeneca UK vaccine trial drops sub-group with children: U.S. trial register

AstraZeneca, which is developing the vaccine along with the University of Oxford, did not immediately respond to a request for comment.

Published 14 Dec, 2020 07:33pm

Business & Finance

AstraZeneca to buy Alexion for $39bn to expand in immunology

AstraZeneca to pay $60 in cash, $115 in equity per Alexion share.
To finance equity component with capital increase.
Expects deal to immediately boost core earnings.

Published 13 Dec, 2020 12:54am

Business & Finance

AstraZeneca to buy Alexion for $39 bln to expand in immunology

Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Alexion shares closed at around $121 apiece on Friday.

Published 12 Dec, 2020 08:06pm

World

AstraZeneca to test combining COVID-19 vaccine with Russian shot

The developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.

Published 11 Dec, 2020 06:14pm

World

Australian Covid vaccine dropped over false positive HIV result

The government said the announcement did not change the planned roll-out of other vaccines to begin in March.

Published 11 Dec, 2020 09:55am

World

Japan plans vaccine freezer buying binge as Tokyo reports record cases

Japan, with a population of 126 million, has agreements to buy a total of 290 million doses of vaccines from Pfizer Inc, AstraZeneca Plc and Moderna Inc, or enough for 145 million people.

Published 10 Dec, 2020 04:58pm

Business & Finance

India seeks more data for emergency AstraZeneca shot approval

The regulator said it had asked the Serum Institute of India, which is the local manufacturer of the AstraZeneca vaccine.
The regulator also recommended Phase I/II trials for a vaccine candidate developed by Gennova Biopharmaceuticals Ltd, based in the western Indian city of Pune.

Published 10 Dec, 2020 01:11am

World

India may authorise some COVID-19 vaccines in weeks, says health secretary

Six vaccines, including Astra Zeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Federal health secretary Rajesh Bhushan told a press conference.

Published 08 Dec, 2020 06:29pm

Markets

Indian shares hit record highs on Reliance, Maruti boost

State-run Canara Bank Ltd surged 7.7% as it launched a qualified institutional placement of shares to raise 20 billion rupees ($270.93 million).

Published 08 Dec, 2020 01:08pm

US AstraZeneca vaccine trial will clear confusion on how well it works: US scientist

Results and potentially a request for US emergency use authorization by AstraZeneca could come in late January, he said.

Published 08 Dec, 2020 10:09am

South Korea to buy millions of vaccine doses as coronavirus cases surge

Health authorities predicted daily cases would hover between 550 and 750 this week, and possibly spike to as much as 900 next week.

Published 08 Dec, 2020 09:10am

World

Swiss say Pfizer/Biontech will deliver 3 million doses of vaccine

With two doses likely to be necessary, the contract means one and half million people in the country could be vaccinated, the government added in a statement.

Published 07 Dec, 2020 07:33pm

World

India considering accelerated review of COVID-19 vaccine emergency use: govt official

Serum Institute is making AstraZeneca's COVID-19 vaccine in India and has applied for emergency use authorization.

Published 07 Dec, 2020 05:03pm

World

Norway to use three vaccines to stop COVID-19 from early 2021

In the first quarter of 2021, Oslo expects to receive a total of 2.5 million doses, covering 1.25 million people, pending approval of the vaccines from European regulators. Norway's population is 5.4 million.

Published 04 Dec, 2020 06:00pm

World

Ten COVID-19 vaccines seen by mid-year, head of global pharma group says

Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials.

Published 28 Nov, 2020 10:35am

Markets

Dollar edges down, set for weekly loss; Aussie and Kiwi rise

At 0831 GMT, the dollar was at 91.953 versus a basket of currencies, down 0.1pc on the day and close to its lowest in three months.

Published 27 Nov, 2020 03:58pm

Business & Finance

CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine

Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study.
The news comes as AstraZeneca faces questions about its success rate that some experts say could hinder its chances of getting speedy US and EU regulatory approval.

Published 26 Nov, 2020 10:38pm

World

Philippines, private firms to sign vaccine supply deal with AstraZeneca

The deal will augment government efforts to lock in supplies to inoculate around two-thirds of its 108 million population, and is another boost for AstraZeneca.

Published 26 Nov, 2020 04:09pm

Markets

Gold slips on AstraZeneca boost to vaccine race

Spot gold edged 0.1pc lower to $1,868.26 per ounce by 0952 GMT and U.S. gold futures fell 0.3pc to $1,866.80.

Published 23 Nov, 2020 05:30pm

Astra/Oxford seek coronavirus vaccine approval after 'effective' trials

US biotech giant Pfizer and German partner BioNTech have already sought approval to roll out their coronavirus vaccine early.

Published 23 Nov, 2020 04:41pm

World

Oxford’s COVID-19 vaccine can be 90% effective, results show

The vaccine developed by Oxford University was 90% effective in preventing COVID-19 when it was administered as a half dose followed by a full dose at least one month apart, according to data from the late-stage trials in Britain and Brazil.

Updated 23 Nov, 2020 03:19pm

World

Volunteer dies during COVID-19 vaccine trial in Brazil

The vaccine was developed by AstraZeneca and Oxford University.

Published 22 Oct, 2020 03:32pm

Business & Finance

AstraZeneca could profit from COVID-19 vaccine as early as July

The London-listed firm previously said it would not profit from the vaccine "during the pandemic".
AstraZeneca, which developed the vaccine with Oxford University, signed multiple supply-and-manufacture deals for more than 3 billion doses globally.

Published 08 Oct, 2020 12:46am

Business & Finance

Canada has signed deal for AstraZeneca vaccine candidate: PM

Trudeau also told a news conference that Ottawa would invest C$440 million ($328 million) in the COVID-19 vaccine Global Access Facility.
The AstraZeneca medication is among the leading candidates in the global race for a vaccine, now in late-stage trials in Britain, South Africa and elsewhere.

Published 26 Sep, 2020 12:07am

Business & Finance

AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept says

The move, confirmed to Reuters by director of affordable medicines in the health department, Khadija Jamaloodien, comes after the British drugmaker.
Tests remain on hold in the United States pending an investigation and the Serum Institute of India.

Published 15 Sep, 2020 08:22pm

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Apr 19	278.45
USD PKR Interbank Buying / Apr 19	278.15
USD to Japanese Yen / Apr 19	154.37
USD to Swiss Franc / Apr 19	0.91
Pound Sterling to USD / Apr 19	1.24
Euro to USD / Apr 19	1.06

Stock	Volume
S&P 500 / Apr 18	5011.12
Nasdaq / Apr 18	15601.50
Dow Jones / Apr 18	37775.38
India Sensex / Apr 19	72222.48
Tokyo Nikkei / Apr 19	37068.35
Hang Seng / Apr 19	16205.02
FTSE 100 / Apr 19	7834.89
Germany DAX 30 / Apr 19	17717.67

Item	Value
Karachi Cotton PKR/37.32 KG / Apr 18	21735
Gold 10 Grams PKR / Apr 18	214077
Crude Oil USD/Barrel / Apr 19	84.27
Gold Spot USD/Ounce / Apr 19	2382.04
Cotton US¢/pound / Apr 19	80.67
Petrol/Litre / Apr 20	293.94

Gainers
Losers
Leaders

Stock	Price
786 Invest Ltd / Apr 20 786 Investments Limited(786)	5 ▼ 0.00 (0.00%)
AL-Abbas Sugar / Apr 20 Al-Abbas Sugar Mills Limited(AABS)	585 ▼ 0.00 (0.00%)
Agro Allianz / Apr 20 Agro Allianz Limited(AAL)	16 ▼ 0.00 (0.00%)
AL-Abid Silk / Apr 20 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Apr 20 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Apr 20 Allied Bank Limited(ABL)	87.10 ▼ 0.00 (0.00%)
Abbott Lab. / Apr 20 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▼ 0.00 (0.00%)
Abson Ind. / Apr 20 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / Apr 20 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▼ 0.00 (0.00%)

Stock	Price
786 Invest Ltd / Apr 20 786 Investments Limited(786)	5 ▲ 0.00 (0.00%)
AL-Abbas Sugar / Apr 20 Al-Abbas Sugar Mills Limited(AABS)	585 ▲ 0.00 (0.00%)
Agro Allianz / Apr 20 Agro Allianz Limited(AAL)	16 ▲ 0.00 (0.00%)
AL-Abid Silk / Apr 20 Al-Abid Silk Mills Limited(AASM)	3.49 ▲ 0.00 (0.00%)
Ali Asghar / Apr 20 Ali Asghar Textile Mills Limited(AATM)	2.07 ▲ 0.00 (0.00%)
Allied Bank / Apr 20 Allied Bank Limited(ABL)	87.10 ▲ 0.00 (0.00%)
Abbott Lab. / Apr 20 Abbott Laboratories (Pakistan) Limited(ABOT)	499.34 ▲ 0.00 (0.00%)
Abson Ind. / Apr 20 Abson Industries Limited(ABSON)	2.50 ▲ 0.00 (0.00%)
Alfalah ETF. / Apr 20 Alfalah Consumer Index ETF.(ACIETF)	9.84 ▲ 0.00 (0.00%)

Stock	Volume
P.I.A.C.(A) / Apr 20 Pakistan International Airlines Corp(PIAA)	47,200,500 ▲ 0.00
Cnergyico PK / Apr 20 Cnergyico PK Limited(CNERGY)	29,719,327 ▲ 0.00
Pak Petroleum / Apr 20 Pakistan Petroleum Limited(PPL)	21,170,581 ▲ 0.00
Pak Refinery / Apr 20 Pakistan Refinery Limited(PRL)	16,965,134 ▲ 0.00
The Searle Co. / Apr 20 The Searle Company Limited(SEARL)	15,793,227 ▲ 0.00
P.T.C.L. / Apr 20 Pakistan Telecommunication Company Ltd(PTC)	15,054,641 ▲ 0.00
K-Electric Ltd. / Apr 20 K-Electric Limited(KEL)	14,145,556 ▲ 0.00
WorldCall Telecom / Apr 20 Worldcall Telecom Limited(WTL)	13,158,668 ▲ 0.00
Telecard Limited / Apr 20 Telecard Limited(TELE)	12,358,668 ▲ 0.00

Markets →

Calculate your monthly liability in FY24

AstraZeneca

Most Popular